Telomere Length and Correlation with Histopathogenesis in B-cell Leukemias/lymphomas
Overview
Authors
Affiliations
Telomere length was recently reported to correlate with cellular origin of B-cell malignancies in relation to the germinal center (GC). In this report, we measured telomere length by quantitative-PCR in 223 B-cell lymphomas/leukemias and correlated results with immunoglobulin (Ig) mutation status and immunostainings for GC/non-GC subtypes of diffuse large B-cell lymphoma (DLBCL). Shortest telomeres were found in Ig-unmutated chronic lymphocytic leukemia (CLL) [median telomere to single copy gene value (T/S) 0.33], differing significantly to Ig-mutated CLL (0.63). Contrary to this, mantle cell lymphomas (MCLs) exhibited similar telomere lengths regardless of Ig mutation status (0.47). Telomere length differed significantly between GC-like (0.73) and non-GC-like DLBCLs (0.43), and follicular lymphomas (FLs) had shorter telomeres (0.53) than GC-DLBCL. Hairy cell leukemias, which display Ig gene intraclonal heterogeneity, had longer telomeres (0.62) than FLs and non-GC-DLBCL, but shorter than GC-DLBCL. We conclude that although DLBCL and CLL subsets can be clearly distinguished, telomere length reflects many parameters and may not simply correlate with GC-related origin.
Zhuang X, Chen P, Yang R, Man X, Wang R, Shi Y Clin Epigenetics. 2024; 16(1):120.
PMID: 39192284 PMC: 11351094. DOI: 10.1186/s13148-024-01728-5.
Carlund O, Thorn E, Osterman P, Fors M, Dernstedt A, Forsell M Clin Epigenetics. 2024; 16(1):68.
PMID: 38773655 PMC: 11110316. DOI: 10.1186/s13148-024-01680-4.
Olbertova H, Plevova K, Pavlova S, Malcikova J, Kotaskova J, Stranska K BMC Cancer. 2022; 22(1):137.
PMID: 35114947 PMC: 8812042. DOI: 10.1186/s12885-022-09221-z.
Telomere Length and Hematological Disorders: A Review.
Dias Nogueira B, Machado C, Montenegro R, de Moraes M, Moreira-Nunes C In Vivo. 2020; 34(6):3093-3101.
PMID: 33144412 PMC: 7811674. DOI: 10.21873/invivo.12142.
Impact of telomere length on survival in classic and variant hairy cell leukemia.
Arons E, Zhou H, Edelman D, Gomez A, Steinberg S, Petersen D Leuk Res. 2015; 39(12):1360-6.
PMID: 26520623 PMC: 4661072. DOI: 10.1016/j.leukres.2015.09.015.